MODERNA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 128.3 USD | +2.11% |
|
+5.99% | +29.03% |
| May. 14 | Investors need more than PPI to make up their minds |  |
| May. 14 | ANALYST RECOMMENDATIONS : Nike, Roblox, Starbucks, Walmart, Deckers Outdoor... | |
ETFs positioned on Moderna, Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 5.66% | 0 M€ | 0.00% | - | |
| 4.69% | 2 M€ | -.--% | ||
| 4.08% | 0 M€ | 0.00% | - | |
| 2.50% | 1 M€ | -2.17% | - | |
| 2.40% | 17 M€ | +6.46% | - | |
| 2.08% | 7 M€ | -.--% | - | |
| 1.81% | 8 M€ | +4.88% | ||
| 1.36% | 9 M€ | -4.31% | - | |
| 1.21% | 1 M€ | +2.21% | - | |
| 0.90% | 1,100 M€ | +3.18% | ||
| 0.81% | 0 M€ | 0.00% | - | |
| 0.72% | 2 M€ | +9.27% | ||
| 0.63% | 3 M€ | 0.00% | - | |
| 0.60% | 9 M€ | -.--% | - | |
| 0.55% | 5 M€ | -72.95% | - | |
| 0.45% | 15 M€ | 0.00% | - | |
| 0.34% | 37 M€ | -.--% | ||
| 0.30% | 22 M€ | +14.86% | ||
| 0.22% | 368 M€ | +19.00% | - | |
| 0.21% | 7 M€ | +6.18% | - | |
| 0.21% | 32 M€ | +1.80% | - | |
| 0.21% | 17 M€ | +6.18% | - |
Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows:
- revenue from product sales (95.7%) ;
- revenues from grants (4%);
- revenues from collaboration agreements (0.3%).
At the end of 2021, the group possessed a portfolio of 15 products in clinical development, of which 3 in phase III, 8 in phase II and 4 in phase I, and 12 products in preclinical development.
Net sales are distributed geographically as follows: the United States (33.4%), Europe (37.1%) and other (29.5%).
Calendar
2024-05-31
- Bernstein Strategic Decisions Conference
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
125.7
USD
Average target price
138.5
USD
Spread / Average Target
+10.22%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +29.03% | 48.16B | |
| -0.10% | 41.73B | |
| +43.45% | 41.03B | |
| -5.26% | 28.77B | |
| +11.48% | 25.59B | |
| -22.74% | 18.96B | |
| +9.06% | 12.92B | |
| +30.01% | 12.03B | |
| -1.51% | 11.77B | |
| +22.69% | 11.73B |
- Stock Market
- Equities
- MRNA Stock
- Funds and ETFs Moderna, Inc.